Bergen Brunswig Rises 3%; Beckman, ICU Medical Improve

Bergen Brunswig Corp.: The Orange supplier of pharmaceuticals and health care products said its third-quarter profit totaled $15 million, or 41 cents a share, a gain of 3% from earnings of $14.5 million, or 40 cents a share, for the same period a year earlier. Sales for the quarter, which ended June 30, increased to $1.9 billion from $1.8 billion. For the first three quarters of its fiscal year, the company had profit of $39.9 million, or $1.09 a share. That compared to earnings of $39.2 million, or $1.08 a share, including a one-time charge of $2.6 million, for the same period a year earlier. Nine-month revenue rose 10% to $5.6 billion from $5.1 billion.